CN113968827A - Regeneration treatment process for waste material in cephalosporin production in pharmaceutical industry - Google Patents

Regeneration treatment process for waste material in cephalosporin production in pharmaceutical industry Download PDF

Info

Publication number
CN113968827A
CN113968827A CN202010712557.3A CN202010712557A CN113968827A CN 113968827 A CN113968827 A CN 113968827A CN 202010712557 A CN202010712557 A CN 202010712557A CN 113968827 A CN113968827 A CN 113968827A
Authority
CN
China
Prior art keywords
kettle
hydrogen peroxide
dibenzothiazyl disulfide
mercaptobenzothiazole
dissolving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010712557.3A
Other languages
Chinese (zh)
Inventor
周广林
钟浩硕
李江水
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dongying Chenhong Rubber Additives Co ltd
Original Assignee
Dongying Chenhong Rubber Additives Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dongying Chenhong Rubber Additives Co ltd filed Critical Dongying Chenhong Rubber Additives Co ltd
Priority to CN202010712557.3A priority Critical patent/CN113968827A/en
Publication of CN113968827A publication Critical patent/CN113968827A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70Sulfur atoms
    • C07D277/76Sulfur atoms attached to a second hetero atom
    • C07D277/78Sulfur atoms attached to a second hetero atom to a second sulphur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

The invention discloses a regeneration treatment process for waste materials in cephalosporin production in pharmaceutical industry. Adding the recovered mercaptobenzothiazole into a dissolving kettle (ethanol, acetone or isopropanol is added into the reaction kettle), heating and dissolving, carrying out hot filter pressing on the mercaptobenzothiazole into an adsorption kettle (activated carbon, argil or nano-scale silica spheres are added into the reaction kettle), carrying out hot filter pressing on the mercaptobenzothiazole into an oxidation kettle, dripping hydrogen peroxide into the oxidation kettle at the temperature of 60-65 ℃, diluting the hydrogen peroxide to 3% by using a solvent, oxidizing the hydrogen peroxide to obtain DM (dibenzothiazyl disulfide), filtering and vacuum drying the DM which is not dissolved in the used solvent after oxidation, and recovering and reusing a mother solution. Compared with the prior art, the invention has the following advantages: the existing process is to use water phase method acid and alkali to generate sewage, sodium sulfate cannot be treated, the process is carried out under full sealing, nitrogen is used for filter pressing during filter pressing, and the set of equipment can be used for producing various products, so that the process is safe and environment-friendly.

Description

Regeneration treatment process for waste material in cephalosporin production in pharmaceutical industry
Technical Field
The invention relates to treatment of production waste in pharmaceutical industry, in particular to a regeneration treatment process of waste in cephalosporin production in pharmaceutical industry.
Background
Dibenzothiazyl disulfide (DM for short) is an important intermediate for producing cephalosporin active ester, and can react with cephalosporin side chain acid under the action of triphenylphosphine or triethyl phosphite to obtain cephalosporin active ester, such as AE-active ester, ceftazidime active ester, cefdinir active ester, cefixime active ester, etc. The utilization rate of DM in the production process of the cephalosporin active ester is only 50 percent, half of DM exists in the mother liquor of the active ester in the form of a by-product 2-mercaptobenzothiazole (M for short) and is not utilized, and the M is unstable, so that the high-purity product is difficult to obtain by concentrating and recycling the mother liquor to realize recycling. Because no effective technology is available for recycling, a large number of enterprises treat waste residues generated after mother liquor recovery as waste, which causes serious resource waste and environmental pollution.
Therefore, the development of M green recycling technology can greatly reduce the discharge amount of wastes, meet the requirement of circular economy and have important social and economic significance.
Disclosure of Invention
The invention aims to provide a waste regeneration treatment process for producing cephalosporins in pharmaceutical industry aiming at the defects in the prior art.
The technical scheme is as follows: a waste material regeneration treatment process for producing cephalosporins in pharmaceutical industry comprises the following steps:
extraction of dibenzothiazyl disulfide
(1) Adding the recovered mercaptobenzothiazole into a dissolving kettle, adding ethanol or acetone or isopropanol into the dissolving kettle, and heating for dissolving;
(2) after dissolution, hot pressing and filtering the mixture to an adsorption kettle, and adding active carbon or argil or nano-scale silicon dioxide balls into the adsorption kettle;
(3) hot filter pressing the mixture into an oxidation kettle at the temperature of between 60 and 65 ℃;
(4) dropping hydrogen peroxide into the oxidation kettle, diluting the hydrogen peroxide to 3% by using a solvent, and oxidizing to obtain dibenzothiazyl disulfide;
(5) after oxidation, dibenzothiazyl disulfide is not dissolved in the solvent, filtering, vacuum drying, and recovering mother liquor for reuse.
Second, refined dibenzothiazyl disulfide
(1) And (3) adding the recovered DM into a dissolving kettle, dissolving the dissolved M in a solvent, and removing other impurities by filtering, wherein the other impurities are insoluble in the solvent.
(2) Filter-pressing into an adsorption kettle, adding an adsorbent to remove color, removing micro particles, and filtering to remove the adsorbent into an oxidation kettle.
(3) Adding hydrogen peroxide into the oxidation kettle to oxidize M into DM which is insoluble in the solvents, filtering and drying to obtain qualified product refined DM, taking away the solvent in a small amount of the cephalosporin mother liquor in the recovered M by the solvent, separating and recovering the mother liquor, and treating and discharging a small amount of wastewater produced by hydrogen peroxide.
Compared with the prior art, the invention has the following advantages: the existing process is to use water phase method acid and alkali to generate sewage, sodium sulfate cannot be treated, the process is carried out under full sealing, nitrogen is used for filter pressing during filter pressing, and the set of equipment can be used for producing various products, so that the process is safe and environment-friendly.
Drawings
FIG. 1 is a schematic flow chart of the steps of the present invention.
Detailed Description
Furthermore, the terms "first", "second" and "first" are used for descriptive purposes only and are not to be construed as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of that feature. In the description of the present invention, "a plurality" means two or more unless specifically defined otherwise.
Adding the recovered mercaptobenzothiazole into a dissolving kettle (ethanol, acetone or isopropanol is added in the reaction kettle), heating and dissolving, carrying out hot filter pressing on the mercaptobenzothiazole to an adsorption kettle (activated carbon or argil or nano-scale silica spheres are added in the reaction kettle), carrying out hot filter pressing on the mercaptobenzothiazole to an oxidation kettle, dripping hydrogen peroxide into the oxidation kettle at the temperature of 60-65 ℃, diluting the hydrogen peroxide to 3% by using a solvent, oxidizing the hydrogen peroxide to obtain DM (dibenzothiazyl disulfide), dissolving the DM in the used solvent after oxidation, filtering, vacuum drying, and recycling the mother liquor.
The process can also be used for producing refined DM by using normally produced high-purity M, producing byproducts of cephalosporin production, and having a lot of impurities in M, because the cephalosporin production uses mixed solvents, the products are different, the solvents are different, the recovery is difficult to purify, then 49 cephalosporin exist, 29 AE-activities exist, the AE-active substances are used for producing cephalosporin, and M and DM are recovered, and the process is used for secondarily purifying the recovered M to produce DM.
1. And (3) adding the recovered DM into a dissolving kettle, dissolving the dissolved M in a solvent, and removing other impurities by filtering, wherein the other impurities are insoluble in the solvent.
2. Filter-pressing into an adsorption kettle, adding an adsorbent to remove color, removing micro particles, and filtering to remove the adsorbent into an oxidation kettle.
3. Adding hydrogen peroxide into the oxidation kettle to oxidize M into DM which is insoluble in the solvents, filtering and drying to obtain qualified product refined DM, taking away the solvent in a small amount of the cephalosporin mother liquor in the recovered M by the solvent, separating and recovering the mother liquor, and treating and discharging a small amount of wastewater produced by hydrogen peroxide.
The existing process is to use water phase method acid and alkali to generate sewage, sodium sulfate cannot be treated, the process is carried out under full sealing, nitrogen is used for filter pressing during filter pressing, and the set of equipment can be used for producing various products, so that the process is safe and environment-friendly.
Nothing is mentioned about the common general knowledge.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.

Claims (1)

1. A regeneration treatment process for waste materials in cephalosporin production in pharmaceutical industry is characterized in that: the method comprises the following steps:
step one, extracting dibenzothiazyl disulfide:
(1) adding the recovered 2-mercaptobenzothiazole into a dissolving kettle, adding ethanol or acetone or isopropanol into the dissolving kettle, and heating for dissolving;
(2) after dissolution, hot pressing and filtering the mixture to an adsorption kettle, and adding active carbon or argil or nano-scale silicon dioxide balls into the adsorption kettle;
(3) hot filter pressing the mixture into an oxidation kettle at the temperature of between 60 and 65 ℃;
(4) dropping hydrogen peroxide into the oxidation kettle, diluting the hydrogen peroxide to 3% by using a solvent, and oxidizing to obtain dibenzothiazyl disulfide;
(5) after oxidation, dibenzothiazyl disulfide is not dissolved in the used solvent, filtering, vacuum drying, and recycling the mother liquor;
step two, refining dibenzothiazyl disulfide:
(1) adding the recovered dibenzothiazyl disulfide into a dissolving kettle, dissolving the 2-mercaptobenzothiazole in a solvent, and removing other impurities by filtering, wherein the other impurities are insoluble in the solvent;
(2) filter-pressing into an adsorption kettle, adding an adsorbent to remove color, removing micro particles, and filtering to remove the adsorbent to oxygen;
(3) adding hydrogen peroxide into the oxidation kettle, oxidizing the 2-mercaptobenzothiazole into dibenzothiazyl disulfide, wherein the dibenzothiazyl disulfide is insoluble in the solvents, filtering and drying to obtain qualified refined dibenzothiazyl disulfide, taking away the solvents in a small amount of cephalosporin mother liquor in the recovered 2-mercaptobenzothiazole by the solvents, separating and recovering the mother liquor, and discharging a small amount of wastewater produced by hydrogen peroxide after treatment.
CN202010712557.3A 2020-07-22 2020-07-22 Regeneration treatment process for waste material in cephalosporin production in pharmaceutical industry Pending CN113968827A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010712557.3A CN113968827A (en) 2020-07-22 2020-07-22 Regeneration treatment process for waste material in cephalosporin production in pharmaceutical industry

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010712557.3A CN113968827A (en) 2020-07-22 2020-07-22 Regeneration treatment process for waste material in cephalosporin production in pharmaceutical industry

Publications (1)

Publication Number Publication Date
CN113968827A true CN113968827A (en) 2022-01-25

Family

ID=79584925

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010712557.3A Pending CN113968827A (en) 2020-07-22 2020-07-22 Regeneration treatment process for waste material in cephalosporin production in pharmaceutical industry

Country Status (1)

Country Link
CN (1) CN113968827A (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102807533A (en) * 2012-08-25 2012-12-05 华北制药河北华民药业有限责任公司 Method utilizing cefotaxime acid waste-liquor to prepare 2, 2'-dithio-dibenzo thiazole
CN102850293A (en) * 2012-09-14 2013-01-02 温州市嘉力化工有限公司 Refining method of dibenzothiazole disulfide (DM)
CN105418536A (en) * 2015-12-29 2016-03-23 河北合佳医药科技集团有限公司 Method for preparing 2,2'-dithiodibenzothiazole from waste residues generated during process of AE-active ester production
CN107879995A (en) * 2017-10-26 2018-04-06 淄博鑫泉医药技术服务有限公司 The method that the M synthesis DM reclaimed in raffinate is synthesized using cefotaxime acid
CN109111409A (en) * 2018-10-18 2019-01-01 河南省化工研究所有限责任公司 A method of benzothiazole is produced from the waste material of production 2-mercaptobenzothiazole
CN109810075A (en) * 2019-03-03 2019-05-28 朝阳天铭工贸有限公司 A kind of technique of isopropanol method purification DM
CN110330466A (en) * 2019-07-25 2019-10-15 山东金城医药化工有限公司 The method of curing di-mercaptobenzothiazolby is recycled from cephalo active ester production mother liquor
CN110746373A (en) * 2019-12-06 2020-02-04 广东省生物医药技术研究所 Method for preparing 2, 2' -dithiodibenzothiazole from crude pinosylvin sodium mother liquor and application thereof
CN111039894A (en) * 2019-11-07 2020-04-21 *** Method for producing DM (direct methanol gasoline) by utilizing recycled rubber accelerator M waste

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102807533A (en) * 2012-08-25 2012-12-05 华北制药河北华民药业有限责任公司 Method utilizing cefotaxime acid waste-liquor to prepare 2, 2'-dithio-dibenzo thiazole
CN102850293A (en) * 2012-09-14 2013-01-02 温州市嘉力化工有限公司 Refining method of dibenzothiazole disulfide (DM)
CN105418536A (en) * 2015-12-29 2016-03-23 河北合佳医药科技集团有限公司 Method for preparing 2,2'-dithiodibenzothiazole from waste residues generated during process of AE-active ester production
CN107879995A (en) * 2017-10-26 2018-04-06 淄博鑫泉医药技术服务有限公司 The method that the M synthesis DM reclaimed in raffinate is synthesized using cefotaxime acid
CN109111409A (en) * 2018-10-18 2019-01-01 河南省化工研究所有限责任公司 A method of benzothiazole is produced from the waste material of production 2-mercaptobenzothiazole
CN109810075A (en) * 2019-03-03 2019-05-28 朝阳天铭工贸有限公司 A kind of technique of isopropanol method purification DM
CN110330466A (en) * 2019-07-25 2019-10-15 山东金城医药化工有限公司 The method of curing di-mercaptobenzothiazolby is recycled from cephalo active ester production mother liquor
CN111039894A (en) * 2019-11-07 2020-04-21 *** Method for producing DM (direct methanol gasoline) by utilizing recycled rubber accelerator M waste
CN110746373A (en) * 2019-12-06 2020-02-04 广东省生物医药技术研究所 Method for preparing 2, 2' -dithiodibenzothiazole from crude pinosylvin sodium mother liquor and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
殷旭光等: "噻唑类硫化促进剂合成进展", 《应用化工》, vol. 40, no. 05, pages 892 - 896 *

Similar Documents

Publication Publication Date Title
JP7082717B2 (en) Industrial waste salt recycling method and equipment
CN110695059B (en) Industrial organic waste salt treatment process
CN109911918B (en) Resource utilization method of industrial mixed salt containing organic solvent
CN109019634B (en) Chemical waste salt refining and resource utilization system and method
CN109368668B (en) Waste sulfuric acid treatment method
CN111334095A (en) Deashing process method of waste tire pyrolysis carbon black
CN104232920A (en) Separation method of various precious metals
CN102634011B (en) Poly-p-phenylene terephthamide (PPTA) polymer washing and solvent recovery method
CN103964445A (en) Quartz sand pickling comprehensive recycle method
CN109020801B (en) Method for recovering p-chlorobenzoic acid as byproduct in p-chlorobenzaldehyde production process
CN113800542A (en) High-efficiency resource utilization technology for coking desulfurization ash
CN113968827A (en) Regeneration treatment process for waste material in cephalosporin production in pharmaceutical industry
CN103482587A (en) Purification recovery process of waste sulfuric acid rich in organic impurity
CN106866399B (en) Tetrachlorobenzoquinone and preparation method thereof
JPH03275645A (en) Preparation of highly pure terephthalic acid
CN112079364B (en) Method for recycling fluorine-and iodine-containing waste material resources
CN106587067A (en) Method for recycling silicon powder from silicon-containing waste residues
CN211098293U (en) Equipment of wet process deacidification
CN112441613B (en) Recycling method of titanium liquid in titanium dioxide acidolysis sludge
CN106219526A (en) A kind of method of purification of micro crystal graphite
CN112063858A (en) Process for producing qualified arsenic oxide from arsenic-containing material by full-wet method
TW201708100A (en) Process for recycling use of waste acids capable of producing high purity sulfuric acid that meets requirements of the semiconductor industry and can be used by the semiconductor industry from waste acids which fail to meet requirements of the semiconductor industry
CN108516556B (en) Method for preparing high-purity silicon dioxide by using silicon slag
CN107200446A (en) A kind of method that trace chromium reclaims aluminium product simultaneously in removal aluminum alloy sludge
JP2000070934A (en) Treatment of terephthalic waste water and its treating device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination